PubMed ID:
36637994
Public Release Type:
Journal
Publication Year: 2023
Affiliation: Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
DOI:
https://doi.org/10.1210/clinem/dgad019
Authors:
Horton William B, Snell-Bergeon Janet K
Request IDs:
21550
Studies:
Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications
Interventions that decrease mean glucose have reduced rates of micro- and macrovascular complications in type 1 diabetes (T1D). However, the difference in cardiovascular risk between people with T1D and the general population endures, suggesting that factors beyond hemoglobin A1C (HbA1c) normalization drive cardiovascular outcomes.